title: T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies.
authors.forename: E R
authors.initials: ER
authors.lastname: van Wering
authors.forename: B E
authors.initials: BE
authors.lastname: van der Linden-Schrever
authors.forename: V H
authors.initials: VH
authors.lastname: van der Velden
authors.forename: T
authors.initials: T
authors.lastname: Szczepański
authors.forename: J J
authors.initials: JJ
authors.lastname: van Dongen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D018365:Neoplasm, Residual / Q000235:genetics / Q000473:pathology*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology*